Kangpu Biopharmaceuticals, Ltd.

About:

Kangpu Bio-Pharma is a clinical stage company.

Website: https://www.kangpugroup.com/

Top Investors: Northern Light Venture Capital, Shenzhen Guozhong Venture Capital Management, Furong Capital, Yinxinggu Capital, Yijing Capital

Description:

Kangpu is focused on developing small molecule drugs targeting immuno-modulating sites to develop treatments for cancer, autoimmune diseases and inflammation. The company has developed proprietary technologies to generate and degrade ubiquitin-protein. It also has a drug discovery combination platform called X-Synergy®.